Hematologic Malignancy
B-Cell Non-Hodgkin Lymphoma
CI-CAN-00000471Explore in graph →
Hematologic1,757 active trials43 approved drugs73 evidence items
Loading cancer entity…
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00000471Explore in graph →
Research activity
Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.
| Window | Period | Records (count) | Exact query | Computed | Source |
|---|---|---|---|---|---|
| All time | … → 2026-09-28 | 49,064 | ("B-Cell Non-Hodgkin Lymphoma"[tiab] OR "B-cell lymphoma"[tiab] OR "Mature B-Cell Neoplasms"[tiab] OR "B-Cell Non Hodgkin's Lymphoma"[tiab] OR "Non-Hodgkin's B-Cell Lymphoma"[tiab] OR "Non-Hodgkin's Lymphoma B-Cell"[tiab] OR "Lymphomas Non-Hodgkin's B-Cell"[tiab] OR "Unspecified B-cell lymphoma, unspecified site"[tiab]) | 2026-09-28 | pubmed |
| Last 5 years | 2021-01-01 → 2026-12-31 | 18,128 | ("B-Cell Non-Hodgkin Lymphoma"[tiab] OR "B-cell lymphoma"[tiab] OR "Mature B-Cell Neoplasms"[tiab] OR "B-Cell Non Hodgkin's Lymphoma"[tiab] OR "Non-Hodgkin's B-Cell Lymphoma"[tiab] OR "Non-Hodgkin's Lymphoma B-Cell"[tiab] OR "Lymphomas Non-Hodgkin's B-Cell"[tiab] OR "Unspecified B-cell lymphoma, unspecified site"[tiab]) AND (2021/01/01:2026/12/31[dp]) | 2026-09-28 | pubmed |
| Preceding 5-year window | 2020-09-28 → 2025-09-27 | 15,566 | ("B-Cell Non-Hodgkin Lymphoma"[tiab] OR "B-cell lymphoma"[tiab] OR "Mature B-Cell Neoplasms"[tiab] OR "B-Cell Non Hodgkin's Lymphoma"[tiab] OR "Non-Hodgkin's B-Cell Lymphoma"[tiab] OR "Non-Hodgkin's Lymphoma B-Cell"[tiab] OR "Lymphomas Non-Hodgkin's B-Cell"[tiab] OR "Unspecified B-cell lymphoma, unspecified site"[tiab]) AND (2020/09/28:2025/09/27[dp]) | 2026-09-28 | pubmed |
| Last 12 months | 2025-09-28 → 2026-09-28 | 3,751 | ("B-Cell Non-Hodgkin Lymphoma"[tiab] OR "B-cell lymphoma"[tiab] OR "Mature B-Cell Neoplasms"[tiab] OR "B-Cell Non Hodgkin's Lymphoma"[tiab] OR "Non-Hodgkin's B-Cell Lymphoma"[tiab] OR "Non-Hodgkin's Lymphoma B-Cell"[tiab] OR "Lymphomas Non-Hodgkin's B-Cell"[tiab] OR "Unspecified B-cell lymphoma, unspecified site"[tiab]) AND (2025/09/28:2026/09/28[dp]) | 2026-09-28 | pubmed |
| y2016 | 2016-01-01 → 2016-12-31 | 2,450 | ("B-Cell Non-Hodgkin Lymphoma"[tiab] OR "B-cell lymphoma"[tiab] OR "Mature B-Cell Neoplasms"[tiab] OR "B-Cell Non Hodgkin's Lymphoma"[tiab] OR "Non-Hodgkin's B-Cell Lymphoma"[tiab] OR "Non-Hodgkin's Lymphoma B-Cell"[tiab] OR "Lymphomas Non-Hodgkin's B-Cell"[tiab] OR "Unspecified B-cell lymphoma, unspecified site"[tiab]) AND (2016/01/01:2016/12/31[dp]) | 2026-09-28 | pubmed |
| y2017 | 2017-01-01 → 2017-12-31 | 2,595 | ("B-Cell Non-Hodgkin Lymphoma"[tiab] OR "B-cell lymphoma"[tiab] OR "Mature B-Cell Neoplasms"[tiab] OR "B-Cell Non Hodgkin's Lymphoma"[tiab] OR "Non-Hodgkin's B-Cell Lymphoma"[tiab] OR "Non-Hodgkin's Lymphoma B-Cell"[tiab] OR "Lymphomas Non-Hodgkin's B-Cell"[tiab] OR "Unspecified B-cell lymphoma, unspecified site"[tiab]) AND (2017/01/01:2017/12/31[dp]) | 2026-09-28 | pubmed |
| y2018 | 2018-01-01 → 2018-12-31 | 2,928 | ("B-Cell Non-Hodgkin Lymphoma"[tiab] OR "B-cell lymphoma"[tiab] OR "Mature B-Cell Neoplasms"[tiab] OR "B-Cell Non Hodgkin's Lymphoma"[tiab] OR "Non-Hodgkin's B-Cell Lymphoma"[tiab] OR "Non-Hodgkin's Lymphoma B-Cell"[tiab] OR "Lymphomas Non-Hodgkin's B-Cell"[tiab] OR "Unspecified B-cell lymphoma, unspecified site"[tiab]) AND (2018/01/01:2018/12/31[dp]) | 2026-09-28 | pubmed |
| y2019 | 2019-01-01 → 2019-12-31 | 2,920 | ("B-Cell Non-Hodgkin Lymphoma"[tiab] OR "B-cell lymphoma"[tiab] OR "Mature B-Cell Neoplasms"[tiab] OR "B-Cell Non Hodgkin's Lymphoma"[tiab] OR "Non-Hodgkin's B-Cell Lymphoma"[tiab] OR "Non-Hodgkin's Lymphoma B-Cell"[tiab] OR "Lymphomas Non-Hodgkin's B-Cell"[tiab] OR "Unspecified B-cell lymphoma, unspecified site"[tiab]) AND (2019/01/01:2019/12/31[dp]) | 2026-09-28 | pubmed |
| y2020 | 2020-01-01 → 2020-12-31 | 3,052 | ("B-Cell Non-Hodgkin Lymphoma"[tiab] OR "B-cell lymphoma"[tiab] OR "Mature B-Cell Neoplasms"[tiab] OR "B-Cell Non Hodgkin's Lymphoma"[tiab] OR "Non-Hodgkin's B-Cell Lymphoma"[tiab] OR "Non-Hodgkin's Lymphoma B-Cell"[tiab] OR "Lymphomas Non-Hodgkin's B-Cell"[tiab] OR "Unspecified B-cell lymphoma, unspecified site"[tiab]) AND (2020/01/01:2020/12/31[dp]) | 2026-09-28 | pubmed |
| y2021 | 2021-01-01 → 2021-12-31 | 3,334 | ("B-Cell Non-Hodgkin Lymphoma"[tiab] OR "B-cell lymphoma"[tiab] OR "Mature B-Cell Neoplasms"[tiab] OR "B-Cell Non Hodgkin's Lymphoma"[tiab] OR "Non-Hodgkin's B-Cell Lymphoma"[tiab] OR "Non-Hodgkin's Lymphoma B-Cell"[tiab] OR "Lymphomas Non-Hodgkin's B-Cell"[tiab] OR "Unspecified B-cell lymphoma, unspecified site"[tiab]) AND (2021/01/01:2021/12/31[dp]) | 2026-09-28 | pubmed |
| y2022 | 2022-01-01 → 2022-12-31 | 3,353 | ("B-Cell Non-Hodgkin Lymphoma"[tiab] OR "B-cell lymphoma"[tiab] OR "Mature B-Cell Neoplasms"[tiab] OR "B-Cell Non Hodgkin's Lymphoma"[tiab] OR "Non-Hodgkin's B-Cell Lymphoma"[tiab] OR "Non-Hodgkin's Lymphoma B-Cell"[tiab] OR "Lymphomas Non-Hodgkin's B-Cell"[tiab] OR "Unspecified B-cell lymphoma, unspecified site"[tiab]) AND (2022/01/01:2022/12/31[dp]) | 2026-09-28 | pubmed |
| y2023 | 2023-01-01 → 2023-12-31 | 3,281 | ("B-Cell Non-Hodgkin Lymphoma"[tiab] OR "B-cell lymphoma"[tiab] OR "Mature B-Cell Neoplasms"[tiab] OR "B-Cell Non Hodgkin's Lymphoma"[tiab] OR "Non-Hodgkin's B-Cell Lymphoma"[tiab] OR "Non-Hodgkin's Lymphoma B-Cell"[tiab] OR "Lymphomas Non-Hodgkin's B-Cell"[tiab] OR "Unspecified B-cell lymphoma, unspecified site"[tiab]) AND (2023/01/01:2023/12/31[dp]) | 2026-09-28 | pubmed |
| y2024 | 2024-01-01 → 2024-12-31 | 3,340 | ("B-Cell Non-Hodgkin Lymphoma"[tiab] OR "B-cell lymphoma"[tiab] OR "Mature B-Cell Neoplasms"[tiab] OR "B-Cell Non Hodgkin's Lymphoma"[tiab] OR "Non-Hodgkin's B-Cell Lymphoma"[tiab] OR "Non-Hodgkin's Lymphoma B-Cell"[tiab] OR "Lymphomas Non-Hodgkin's B-Cell"[tiab] OR "Unspecified B-cell lymphoma, unspecified site"[tiab]) AND (2024/01/01:2024/12/31[dp]) | 2026-09-28 | pubmed |
| y2025 | 2025-01-01 → 2025-12-31 | 3,812 | ("B-Cell Non-Hodgkin Lymphoma"[tiab] OR "B-cell lymphoma"[tiab] OR "Mature B-Cell Neoplasms"[tiab] OR "B-Cell Non Hodgkin's Lymphoma"[tiab] OR "Non-Hodgkin's B-Cell Lymphoma"[tiab] OR "Non-Hodgkin's Lymphoma B-Cell"[tiab] OR "Lymphomas Non-Hodgkin's B-Cell"[tiab] OR "Unspecified B-cell lymphoma, unspecified site"[tiab]) AND (2025/01/01:2025/12/31[dp]) | 2026-09-28 | pubmed |
Data updated 3 days agoSource updated unknownsource: pubmed E-utilities
Literature
Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.
· 2011 · PMID 22158541 · validated cbioportal_study pubmed
· 2012 · PMID 22343534 · validated cbioportal_study pubmed
· 2018 · PMID 29713087 · validated cbioportal_study pubmed
· 2017 · PMID 28985567 · validated cbioportal_study pubmed
· 2013 · PMID 23415222 · validated cbioportal_study pubmed
· 2024 · PMID 38497151 · validated cbioportal_study pubmed
· 2023 · PMID 36201743 · validated cbioportal_study pubmed
· 2013 · PMID 24145436 · validated cbioportal_study pubmed
· 2014 · PMID 24434212 · validated cbioportal_study pubmed
· 2015 · PMID 25991819 · validated cbioportal_study pubmed
· 2024 · PMID 38995739 · validated cbioportal_study pubmed